Hui‐Ching Wang

1.6k total citations
63 papers, 1.2k citations indexed

About

Hui‐Ching Wang is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Hui‐Ching Wang has authored 63 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 13 papers in Molecular Biology and 12 papers in Epidemiology. Recurrent topics in Hui‐Ching Wang's work include Head and Neck Cancer Studies (8 papers), Numerical methods in engineering (6 papers) and Hepatitis B Virus Studies (6 papers). Hui‐Ching Wang is often cited by papers focused on Head and Neck Cancer Studies (8 papers), Numerical methods in engineering (6 papers) and Hepatitis B Virus Studies (6 papers). Hui‐Ching Wang collaborates with scholars based in Taiwan, United States and China. Hui‐Ching Wang's co-authors include Ih‐Jen Su, Han‐Chieh Wu, Wenya Huang, P. K. Banerjee, Huan‐Yao Lei, Nelson Fausto, Shih‐Feng Cho, Chien‐Fu Chen, Leong‐Perng Chan and Ming‐Derg Lai and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Hui‐Ching Wang

61 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui‐Ching Wang Taiwan 14 640 454 214 208 155 63 1.2k
Martin Krüger Germany 14 319 0.5× 354 0.8× 145 0.7× 216 1.0× 126 0.8× 26 1.1k
Katsutoshi Sugimoto Japan 27 988 1.5× 1.1k 2.4× 100 0.5× 257 1.2× 73 0.5× 120 2.2k
Chang Wook Kim South Korea 24 1.1k 1.7× 1.3k 2.8× 137 0.6× 205 1.0× 98 0.6× 99 2.0k
Guohong Deng China 22 729 1.1× 647 1.4× 122 0.6× 259 1.2× 215 1.4× 99 1.5k
Manxia Lin China 21 469 0.7× 830 1.8× 234 1.1× 65 0.3× 61 0.4× 79 1.4k
Philipp Wiggermann Germany 30 896 1.4× 1.2k 2.7× 262 1.2× 125 0.6× 171 1.1× 149 2.9k
Yoshiyuki Kanazawa Japan 17 676 1.1× 831 1.8× 73 0.3× 300 1.4× 217 1.4× 31 1.5k
Shaojie Xin China 20 753 1.2× 732 1.6× 75 0.4× 172 0.8× 137 0.9× 92 1.1k
Ikuo Nakamura Japan 21 808 1.3× 931 2.1× 320 1.5× 346 1.7× 194 1.3× 119 1.8k
Jinhua Huang China 19 189 0.3× 428 0.9× 269 1.3× 154 0.7× 101 0.7× 90 1.4k

Countries citing papers authored by Hui‐Ching Wang

Since Specialization
Citations

This map shows the geographic impact of Hui‐Ching Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Ching Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Ching Wang more than expected).

Fields of papers citing papers by Hui‐Ching Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui‐Ching Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Ching Wang. The network helps show where Hui‐Ching Wang may publish in the future.

Co-authorship network of co-authors of Hui‐Ching Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Hui‐Ching Wang. A scholar is included among the top collaborators of Hui‐Ching Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui‐Ching Wang. Hui‐Ching Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Lin‐Quan, Sai-Lan Liu, Muh‐Hwa Yang, et al.. (2025). GFH018 and Toripalimab Combination Therapy for Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: Results from a Phase Ib/II Study. Clinical Cancer Research. 31(16). 3424–3432.
2.
Wang, Hung‐Ming, Pei‐Jen Lou, Jin‐Ching Lin, et al.. (2024). Cetuximab Treatment beyond Progression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Nationwide Population-Based Study (THNS-2021-08). Targeted Oncology. 19(1). 51–58. 1 indexed citations
3.
4.
Luo, Chi‐Wen, Shih‐Feng Cho, Yi‐Chang Liu, et al.. (2023). Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer. Biomedicines. 11(3). 691–691. 2 indexed citations
5.
Wang, Hui‐Ching, Shih‐Feng Cho, Chun‐Chieh Wu, et al.. (2023). The Prognosis Performance of a Neutrophil- and Lymphocyte-Associated Gene Mutation Score in a Head and Neck Cancer Cohort. Biomedicines. 11(12). 3113–3113. 1 indexed citations
6.
7.
Yen, Chia‐Hung, Shu‐Chen Wang, Yi‐Chang Liu, et al.. (2022). Emodin Ameliorates the Efficacy of Carfilzomib in Multiple Myeloma Cells via Apoptosis and Autophagy. Biomedicines. 10(7). 1638–1638. 10 indexed citations
8.
Wang, Hui‐Ching, Chi‐Wen Luo, Tzu-Yi Chen, et al.. (2022). Skp2-mediated Zeb1 expression facilitates cancer migration by a ubiquitination-independent pathway. Life Sciences. 311(Pt A). 121135–121135. 8 indexed citations
9.
Chan, Leong‐Perng, Hui‐Ching Wang, Chen‐Yu Chien, et al.. (2022). Growth regulated oncogene-α contribute to EMT/MMPs pathway by binding its receptors in head and neck squamous cell carcinoma. Life Sciences. 306. 120791–120791. 4 indexed citations
10.
Hsu, Wen‐Hung, Yao‐Hsiang Shih, Fang‐Jung Yu, et al.. (2022). Prevention and management of esophageal stricture after esophageal ESD: 10 years of experience in a single medical center. Journal of the Formosan Medical Association. 122(6). 486–492. 5 indexed citations
11.
Hsiao, Hui‐Hua, Yi‐Chang Liu, Hui‐Ching Wang, et al.. (2022). Comparison of a novel lateral-flow device to galactomannan assay at different time periods for detections of invasive aspergillosis. Journal of the Formosan Medical Association. 121(10). 2123–2129. 6 indexed citations
12.
Wang, Hui‐Ching, Leong‐Perng Chan, Chun‐Chieh Wu, et al.. (2021). Silencing DNA Polymerase β Induces Aneuploidy as a Biomarker of Poor Prognosis in Oral Squamous Cell Cancer. International Journal of Molecular Sciences. 22(5). 2402–2402. 6 indexed citations
13.
14.
Wang, Hui‐Ching, Chia‐Lin Chou, Ching‐Chieh Yang, et al.. (2019). Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy. International Journal of Molecular Sciences. 20(17). 4087–4087. 27 indexed citations
15.
Wang, Hui‐Ching, Ching‐Yuan Kuo, Tsai‐Yun Chen, et al.. (2017). Distinct clinical characteristics of paroxysmal nocturnal hemoglobinuria in patients in Southern Taiwan: A multicenter investigation. The Kaohsiung Journal of Medical Sciences. 33(8). 405–410. 4 indexed citations
16.
Wang, Hui‐Ching, et al.. (2016). The epidemiologic transition of thalassemia and associated hemoglobinopathies in southern Taiwan. Annals of Hematology. 96(2). 183–188. 9 indexed citations
17.
Wang, Hui‐Ching & Shih‐Feng Cho. (2015). Docetaxel for High-Grade Mucoepidermoid Carcinoma of the Lung. SHILAP Revista de lepidopterología. 1 indexed citations
18.
Wang, Hui‐Ching, et al.. (2012). A Local Adaptive Differential Quadrature Method for Multi-Dimensional Inverse Scattering Problem of Wave Propagation. Cmc-computers Materials & Continua. 28(3). 261–280. 2 indexed citations
19.
Wang, Hui‐Ching, et al.. (2006). Hepatitis B virus pre‐S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Science. 97(8). 683–688. 224 indexed citations
20.
Wang, Hui‐Ching, Han‐Chieh Wu, Chien‐Fu Chen, et al.. (2003). Different Types of Ground Glass Hepatocytes in Chronic Hepatitis B Virus Infection Contain Specific Pre-S Mutants that May Induce Endoplasmic Reticulum Stress. American Journal Of Pathology. 163(6). 2441–2449. 194 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Krüger Breakdown of academic impact, for papers by Katsutoshi Sugimoto Breakdown of academic impact, for papers by Chang Wook Kim Breakdown of academic impact, for papers by Guohong Deng Breakdown of academic impact, for papers by Manxia Lin Breakdown of academic impact, for papers by Philipp Wiggermann Breakdown of academic impact, for papers by Yoshiyuki Kanazawa Breakdown of academic impact, for papers by Shaojie Xin Breakdown of academic impact, for papers by Ikuo Nakamura Breakdown of academic impact, for papers by Jinhua Huang
Rankless by CCL
2026